Company / Free Cash Flow per Share
RHYTHM PHARMACEUTICALS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.87
FY2025
5-year range
-$3.33 / -$1.87
FY2021-FY2025
Trend
+2.5%
vs FY2024
Sector context
#129 of 192
Health Care
What the data says
At $-1.87, RHYTHM PHARMACEUTICALS, INC.'s free cash flow per share ranks #129 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 3 consecutive years, from $-3.33 in FY2022 to $-1.87 in FY2025.
Based on SEC 10-K filings.
-1.87 in FY2025.
Improved from $-2.41 to $-1.87 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#129 of 192 in Health CareTop 67% of 192This company -$1.87 Sector average -$19.84
▼
+90.6% above sector average
Key checks
Key Insights
- RHYTHM PHARMACEUTICALS, INC.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 2.5% year-over-year.
- Ranks #129 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.87 | +2.5% |
| FY2024 | -$1.92 | +20.4% |
| FY2023 | -$2.41 | +27.8% |
| FY2022 | -$3.33 | -12.9% |
| FY2021 | -$2.95 | -6.6% |
| FY2020 | -$2.77 | +20.0% |
| FY2019 | -$3.46 | -50.5% |
| FY2018 | -$2.30 | +20.7% |
| FY2017 | -$2.90 | -21.9% |
| FY2016 | -$2.38 | -247.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026